C J S Specialty Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 192.00 Cr
as on 13-12-2024
- Revenue 3.11%
(FY 2021)
- Profit 100.45%
(FY 2021)
- Ebitda 89.47%
(FY 2021)
- Net Worth 35.99%
(FY 2021)
- Total Assets 27.68%
(FY 2021)
About C J S Specialty Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹192.00 Cr.
Ashish Shah, Dharmesh Mange, Ashit Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110MH2008PTC186710
- Company No.
186710
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at C J S Specialty Chemicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmesh Mange  | Director | 12-Sep-2008 | Current |
| Ashish Shah | Director | 12-Sep-2008 | Current |
| Ashit Shah | Director | 12-Sep-2008 | Current |
| Apurva Shah | Director | 12-Sep-2008 | Current |
Financial Performance of C J S Specialty Chemicals.
C J S Specialty Chemicals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 3.11% increase. The company also saw a substantial improvement in profitability, with a 100.45% increase in profit. The company's net worth Soared by an impressive increase of 35.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of C J S Specialty Chemicals?
In 2021, C J S Specialty Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sdk Chemicals (India) Private LimitedActive 18 years 3 monthsAshish Shah and Dharmesh Mange are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Dec 2021 | ₹50.00 Cr | Open |
Others Creation Date: 30 Apr 2021 | ₹3.75 Cr | Open |
Others Creation Date: 05 Oct 2020 | ₹25.00 Cr | Open |
How Many Employees Work at C J S Specialty Chemicals?
C J S Specialty Chemicals has a workforce of 37 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of C J S Specialty Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped C J S Specialty Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
